Well-positioned healthcare sector for the adoption of modern treatments and diagnostic systems, increasing rates of cancer and cardiac diseases and rising awareness regarding the advantages of radiopharmaceuticals are boosting the demand for global radiopharmaceuticals market….
Albany, New York, June 5, 2017: Well-positioned healthcare sector for the adoption of modern treatments and diagnostic systems, increasing rates of cancer and cardiac diseases and rising awareness regarding the advantages of radiopharmaceuticals are boosting…
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Radiopharmaceuticals Market: Will Japan (Expected to Register an Attractive Growth Rate Throughout the Forecast Period) Beat Current Market Leader North America? –…
Albany, New York, May 16, 2017 Radiopharmaceuticals refer to a group of pharmaceutical drugs that exhibit radioactivity, and are used as therapeutic and diagnostic agents as they evoke no physiological response from the patients. These…
North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market North America accounted for more than 40% market share in the global radiopharmaceuticals market in 2016 and is expected…
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of…
Research Beam adds a report on “Global Radiopharmaceuticals Industry 2014 Market Research Report”. The report is designed with an aim to provide the market investors with full-fledged knowledge of the market trends and factors influencing…
